1nhaler

Developer of single‑dose, disposable, dry‑powder inhaler for conditions like asthma, epilepsy, allergies, and Parkinsons

placeEdinburgh, Scotland, United Kingdom calendar_todayFounded 2017 language 1nhaler.com

Social engagement

Social engagement: 1.1K social following, 6 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record; lead investors include Archangels.

Investor typeCountShare
Venture capital120%
Bank & private debt240%
Other / undisclosed240%

Recent activity

23 Mar 2026
Leadership hire
Chair
Coming soon